Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1991 1
1992 2
1993 2
1994 1
1995 3
1996 2
1997 3
1998 2
2002 1
2011 1
2018 3
2019 1
2020 1
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
An overview of take-home naloxone programs in Australia.
Dwyer R, Olsen A, Fowlie C, Gough C, van Beek I, Jauncey M, Lintzeris N, Oh G, Dicka J, Fry CL, Hayllar J, Lenton S. Dwyer R, et al. Among authors: hayllar j. Drug Alcohol Rev. 2018 May;37(4):440-449. doi: 10.1111/dar.12812. Drug Alcohol Rev. 2018. PMID: 29744980
Sulphasalazine in ulcerative colitis: in memoriam?
Hayllar J, Bjarnason I. Hayllar J, et al. Gut. 1991 May;32(5):462-3. doi: 10.1136/gut.32.5.462. Gut. 1991. PMID: 1674925 Free PMC article. Review. No abstract available.
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study.
Valerio H, Alavi M, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Holden J, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Dore GJ, Grebely J. Valerio H, et al. Among authors: hayllar j. Clin Infect Dis. 2021 Jul 1;73(1):e69-e78. doi: 10.1093/cid/ciaa571. Clin Infect Dis. 2021. PMID: 32421194 Free PMC article.
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay.
Lamoury FMJ, Bajis S, Hajarizadeh B, Marshall AD, Martinello M, Ivanova E, Catlett B, Mowat Y, Marks P, Amin J, Smith J, Ezard N, Cock V, Hayllar J, Persing DH, Kleman M, Cunningham P, Dore GJ, Applegate TL, Grebely J; LiveRLife Study Group. Lamoury FMJ, et al. Among authors: hayllar j. J Infect Dis. 2018 May 25;217(12):1889-1896. doi: 10.1093/infdis/jiy114. J Infect Dis. 2018. PMID: 29534185
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A, Valerio H, Peacock A, Degenhardt L, Hayllar J, Harrod ME, Henderson C, Read P, Gilliver R, Christmass M, Dunlop A, Montebello M, Whitton G, Reid D, Lam T, Alavi M, Silk D, Marshall AD, Treloar C, Dore GJ, Grebely J; ETHOS Engage Study Group. Conway A, et al. Among authors: hayllar j. Int J Drug Policy. 2021 Oct;96:103421. doi: 10.1016/j.drugpo.2021.103421. Epub 2021 Aug 25. Int J Drug Policy. 2021. PMID: 34452808
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
Bajis S, Grebely J, Hajarizadeh B, Applegate T, Marshall AD, Ellen Harrod M, Byrne J, Bath N, Read P, Edwards M, Gorton C, Hayllar J, Cock V, Peterson S, Thomson C, Weltman M, Jefferies M, Wood W, Haber P, Ezard N, Martinello M, Maher L, Dore GJ; LiveRLife Study Group. Bajis S, et al. Among authors: hayllar j. J Viral Hepat. 2020 Mar;27(3):281-293. doi: 10.1111/jvh.13233. Epub 2019 Dec 6. J Viral Hepat. 2020. PMID: 31698545
NSAIDs, Cox-2 inhibitors, and the gut.
Hayllar J, Bjarnason I. Hayllar J, et al. Lancet. 1995 Dec 16;346(8990):1629. doi: 10.1016/s0140-6736(95)91962-7. Lancet. 1995. PMID: 7500770 No abstract available.
NSAIDs, Cox-2 inhibitors, and the gut.
Hayllar J, Bjarnason I. Hayllar J, et al. Lancet. 1995 Aug 26;346(8974):521-2. doi: 10.1016/s0140-6736(95)91378-5. Lancet. 1995. PMID: 7658776 No abstract available.
28 results